Tilray Brands (TLRY) Times Interest Earned (2017 - 2026)
Tilray Brands (TLRY) posted Times Interest Earned of -$0.92 for Q1 2026, down 26.33% on a QoQ basis from -$0.73 in Q4 2025, and up 91.32% year-over-year from -$0.48 in Q1 2025.
Tilray Brands (TLRY) Times Interest Earned (2017 - 2026) Analysis & Trends
Tilray Brands' Times Interest Earned history runs 10 years deep, the most recent figure standing at -$0.92 for Q1 2026.
- Quarterly Times Interest Earned rose 91.32% year-over-year to -$0.92 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$52.11 (down 335.74% YoY) and the FY2025 annual result came in at -$2.36, down 964.86% from the prior year.
- Times Interest Earned was -$0.92 for Q1 2026 at Tilray Brands, down from -$0.73 in the prior quarter.
- Across five years, Times Interest Earned topped out at $0.72 in Q3 2025 and bottomed at -$41.26 in Q2 2025.
- A 5-year average of -$5.92 and a median of -$0.87 in 2022 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 246.97% in 2025, while the deepest fall reached 10519.31% in 2025.
- Tilray Brands' Times Interest Earned stood at -$0.87 in 2022, then soared by 35.25% to -$0.57 in 2023, then slipped by 2.6% to -$0.58 in 2024, then slipped by 25.63% to -$0.73 in 2025, then declined by 26.33% to -$0.92 in 2026.
- Business Quant data shows TLRY's Times Interest Earned at -$0.92 in Q1 2026, -$0.73 in Q4 2025, and $0.72 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | -0.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -0.92 |
| Nov 30, 2025 | -0.73 |
| Aug 31, 2025 | 0.72 |
| May 31, 2025 | -41.26 |
| Feb 28, 2025 | -10.63 |
| Nov 30, 2024 | -0.58 |
| Aug 31, 2024 | -0.49 |
| May 31, 2024 | -0.39 |
| Feb 29, 2024 | -1.12 |
| Nov 30, 2023 | -0.57 |
| Aug 31, 2023 | -0.47 |
| May 31, 2023 | -2.46 |
| Feb 28, 2023 | -16.62 |
| Nov 30, 2022 | -0.87 |
| Aug 31, 2022 | -6.22 |
| May 31, 2022 | -17.33 |
| Feb 28, 2022 | -0.68 |
| Nov 30, 2021 | -0.99 |
| Aug 31, 2021 | -1.13 |
| May 31, 2021 | -2.79 |